Related Experiment Videos
Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group study
B G Durie1, J Crowley, C A Coltman
1University of Arizona Cancer Center.
Investigational New Drugs
|November 11, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Current Status of U.S. Clinical Trials in Chronic Lymphocytic Leukemia.
Leukemia & lymphoma·2016
Immunologic Aspects of the Hematologic Neoplasms.
Postgraduate medicine·2016
First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors.
Investigational new drugs·2026
Novel EGFR tyrosine kinase inhibitors exhibiting intrinsic fluorescence.
Investigational new drugs·2026
The novel agent VP79s synergistically enhances venetoclax activity in multiple myeloma cells.
Investigational new drugs·2026